Did you mean mk 4305 of suvorexant of mk 4307 of スボレキサント?
Displaying drugs 101 - 125 of 143 in total
MK-1064
MK-1064 is under investigation in clinical trial NCT02549014 (A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of MK-1064 (MK-1064-001)).
Investigational
Matched Name: … MK-1064 …
Matched Description: … and Pharmacodynamics of MK-1064 (MK-1064-001)). ... MK-1064 is under investigation in clinical trial NCT02549014 (A Single Dose Study of the Safety, Pharmacokinetics …
Matched Description: … and Pharmacodynamics of MK-1064 (MK-1064-001)). ... MK-1064 is under investigation in clinical trial NCT02549014 (A Single Dose Study of the Safety, Pharmacokinetics …
MK-3577
MK-3577 is under investigation in clinical trial NCT00868790 (A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)).
Investigational
Matched Name: … MK-3577 …
Matched Description: … MK-3577 is under investigation in clinical trial NCT00868790 (A Study of the Safety and Efficacy of MK ... -3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)). …
Matched Description: … MK-3577 is under investigation in clinical trial NCT00868790 (A Study of the Safety and Efficacy of MK ... -3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)). …
MK-2748
MK-2748 is under investigation in clinical trial NCT01593735 (A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1)).
Investigational
Matched Name: … MK-2748 …
Matched Description: … and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1)). ... MK-2748 is under investigation in clinical trial NCT01593735 (A Multiple Dose Study to Evaluate the Safety …
Matched Description: … and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1)). ... MK-2748 is under investigation in clinical trial NCT01593735 (A Multiple Dose Study to Evaluate the Safety …
MK-886
MK-886 is an experimental inhibitor of leukotriene synthesis.
Experimental
Matched Name: … MK-886 …
Matched Description: … MK-886 is an experimental inhibitor of leukotriene synthesis. …
Matched Description: … MK-886 is an experimental inhibitor of leukotriene synthesis. …
MK-0354
MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis and related disorders. It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of niacin.
Investigational
Matched Name: … MK-0354 …
Matched Description: … MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis ... , including HDL, or the good cholesterol, similar to the therapeutic action of niacin. ... It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles …
Matched Description: … MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis ... , including HDL, or the good cholesterol, similar to the therapeutic action of niacin. ... It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles …
MK-0812
MK0812 has been used in trials studying the treatment of Relapsing-Remitting Multiple Sclerosis.
Investigational
Matched Name: … MK-0812 …
MK-0893
MK0893 has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2.
Investigational
Matched Name: … MK-0893 …
MK-0767
MK0767 has been used in trials studying the treatment of Dyslipidemia, Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2, and Diabetes Mellitus, Type II, among others.
Investigational
Matched Name: … MK-0767 …
MK-5108
MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors.
Investigational
Matched Name: … MK-5108 …
Matched Description: … MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors. …
Matched Description: … MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors. …
MK-6186
MK6186 has been used in trials studying the treatment of HIV-1 Infection.
Investigational
Matched Name: … MK-6186 …
MK-0873
MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Name: … MK-0873 …
Matched Description: … MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis. …
Matched Description: … MK-0873 has been used in trials studying the treatment of Rheumatoid Arthritis. …
MK-1454
A synthetic cyclic dinucleotide (CDN) and agonist of stimulator of interferon genes protein (STING), with potential immunoactivating and antineoplastic activities. Upon intratumoral (IT) administration, STING agonist MK-1454 binds to STING and activates the STING pathway, which promotes IKK-related kinase TANK-binding kinase 1 (TBK1) signaling and activates nuclear factor-kappa B (NF-kB)...
Investigational
Matched Name: … MK-1454 …
Matched Description: … Upon intratumoral (IT) administration, STING agonist MK-1454 binds to STING and activates the STING pathway …
Matched Description: … Upon intratumoral (IT) administration, STING agonist MK-1454 binds to STING and activates the STING pathway …
MK-6325
MK-6325 is under investigation in clinical trial NCT01329913 (Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)).
Investigational
Matched Name: … MK-6325 …
Matched Description: … of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)). ... MK-6325 is under investigation in clinical trial NCT01329913 (Safety, Pharmacokinetics, and Pharmacodynamics …
Matched Description: … of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)). ... MK-6325 is under investigation in clinical trial NCT01329913 (Safety, Pharmacokinetics, and Pharmacodynamics …
MK-0773
MK-0773 is under investigation in clinical trial NCT00529659 (A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(mk-0773-005)).
Investigational
Matched Name: … MK-0773 …
Matched Description: … MK-0773 is under investigation in clinical trial NCT00529659 (A Study of the Safety and Efficacy of MK ... -0773 in Women With Sarcopenia (Loss of Muscle Mass)(mk-0773-005)). …
Matched Description: … MK-0773 is under investigation in clinical trial NCT00529659 (A Study of the Safety and Efficacy of MK ... -0773 in Women With Sarcopenia (Loss of Muscle Mass)(mk-0773-005)). …
MK-212
MK-212 has been used in trials studying the treatment of Alcoholism.
Investigational
Matched Name: … MK-212 …
Matched Description: … MK-212 has been used in trials studying the treatment of Alcoholism. …
Matched Salts name: … MK-212 hydrochloride …
Matched Description: … MK-212 has been used in trials studying the treatment of Alcoholism. …
Matched Salts name: … MK-212 hydrochloride …
MK-4721
MK-4721 is a fully human monoclonal antibody directed to Agensys’ proprietary target Prostate Stem Cell Antigen (PSCA), an antigen expressed at significant levels on tumor cells from the majority of patients with all stages of prostate, pancreatic and bladder cancers.
Investigational
Matched Name: … MK-4721 …
Matched Description: … MK-4721 is a fully human monoclonal antibody directed to Agensys’ proprietary target Prostate Stem Cell …
Matched Description: … MK-4721 is a fully human monoclonal antibody directed to Agensys’ proprietary target Prostate Stem Cell …
MK-0731
MK-0731 is a kinesin spindle protein inhibitor and antineoplastic agent.
Experimental
Matched Name: … MK-0731 …
Matched Description: … MK-0731 is a kinesin spindle protein inhibitor and antineoplastic agent. …
Matched Description: … MK-0731 is a kinesin spindle protein inhibitor and antineoplastic agent. …
MK-8776
Sch 900776 has been used in trials studying the treatment of Neoplasms, Hodgkin Disease, Adult Erythroleukemia, Lymphoma, Non-Hodgkin, and Myelogenous Leukemia, Acute, among others.
Investigational
Matched Name: … MK-8776 …
MK-0249
MK0249 has been used in trials studying the treatment of Hypopnea Syndrome, Alzheimer's Disease, Paranoid Schizophrenia, Sleep Apnea, Obstructive, and Excessive Daytime Sleepiness, among others.
Investigational
Matched Name: … MK-0249 …
MK-0777
MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized Anxiety Disorder.
Investigational
Matched Name: … MK-0777 …
Matched Description: … MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized …
Matched Description: … MK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized …
MK-1496
MK-1496 has been used in trials studying the treatment of Neoplasms and Malignant.
Investigational
Matched Name: … MK-1496 …
Matched Description: … MK-1496 has been used in trials studying the treatment of Neoplasms and Malignant. …
Matched Description: … MK-1496 has been used in trials studying the treatment of Neoplasms and Malignant. …
MK-0752
Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer).
Investigational
Matched Name: … MK-0752 …
Matched Description: … Recurrent or Refractory CNS Cancer). ... Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With …
Matched Description: … Recurrent or Refractory CNS Cancer). ... Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With …
MK-7622
MK-7622 has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Name: … MK-7622 …
Matched Description: … MK-7622 has been used in trials studying the treatment of Alzheimer's Disease. …
Matched Description: … MK-7622 has been used in trials studying the treatment of Alzheimer's Disease. …
Displaying drugs 101 - 125 of 143 in total